The Quality of Online Resources Available to Patients Interested in Knee Biologic Therapies Is Poor
- 11 Downloads
As the use of biologic therapies for the management of knee pathology continues to expand, it is more likely that patients will turn to the Internet to gather information on this topic. Given the lack of scientific consensus on the use of biologics, care providers must understand what information is available online.
The purpose of this study was to evaluate the quality of websites that patients may use to educate themselves on knee biologics.
Websites were identified using search terms relevant to multiple biologic therapies available for knee pathology. Websites were scored based on an author-derived grading rubric, with a total of 25 possible points relating to the role of knee biologics in the diagnosis, evaluation, and treatment of knee pathology. Websites were categorized based on the source (e.g., physician-operated website vs. industry-related website). Reading level was assessed with the Flesch-Kincaid readability test.
The initial search yielded 375 results, with 96 websites meeting final inclusion criteria. Mean website score was poor, at 6.01 of the 25 possible points (24.0%). Physician websites were the most common, with 60% of the articles identified. Industry-related websites scored the lowest (mean, 3.2 ± 0.97) while hospital-related websites scored the highest (mean, 8.3 ± 2.93). Overall, websites published from hospitals or orthopedic professional societies had significantly higher scores than other websites. The search term “knee PRP” yielded higher-quality results than “knee platelet rich plasma.” Similarly, “knee BMAC” led to better results than “knee bone marrow aspirate concentrate.” The average reading level was 11.4.
Many online resources are available for patients seeking information about knee biologic therapies, but the quality of websites identified was very poor. Patients should be counseled that the information available online for knee biologic therapy is unreliable. Surgeons should play an increased role in providing resources to patients and educating them on biologic options.
Keywordsbiologics knee PRP platelet-rich plasma online resources
Compliance with Ethical Standards
Conflict of Interest
Benedict U. Nwachukwu, MD, MBA, Ryan C. Rauck, MD, Cynthia A. Kahlenberg, MD, Chukwuma Nwachukwu, BS, William W. Schairer, MD, Riley J. Williams III, MD, David W. Altchek, MD, and Answorth A. Allen, MD, declare that they have no conflicts of interest.
Required Author Forms
Disclosure forms provided by the authors are available with the online version of this article.
- 9.LaPrade RF, Geeslin AG, Murray IR, Musahl V, Zlotnicki JP, Petrigliano F, Mann BJ. Biologic treatments for sports injuries II think tank—current concepts, future research, and barriers to advancement, Part 1: biologics overview, ligament injury, tendinopathy. Am J Sports Med. 2016;44:3270–3283.CrossRefPubMedGoogle Scholar
- 13.Weiss BD. Health literacy and patient safety: help patients understand. American Medical Association Foundation. Chicago, IL; 2007.Google Scholar